Why diagnose Parkinson's disease at the 'preclinical' phase

被引：0
|
作者：
Wolters, E. Ch. [1 ]
机构：
[1] VUMC, Dept Neurol, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [21] The relevance of preclinical studies for the treatment of Parkinson's disease
    Gerlach, M
    Foley, P
    Riederer, P
    JOURNAL OF NEUROLOGY, 2003, 250 (Suppl 1) : 31 - 34
  • [22] Are Sleep Disturbances Preclinical Markers of Parkinson's Disease?
    dos Santos, Altair B.
    Kohlmeier, Kristi A.
    Barreto, George E.
    NEUROCHEMICAL RESEARCH, 2015, 40 (03) : 421 - 427
  • [23] Are Sleep Disturbances Preclinical Markers of Parkinson’s Disease?
    Altair B. dos Santos
    Kristi A. Kohlmeier
    George E. Barreto
    Neurochemical Research, 2015, 40 : 421 - 427
  • [24] Emerging preclinical pharmacological targets for Parkinson's disease
    More, Sandeep Vasant
    Choi, Dong-Kug
    ONCOTARGET, 2016, 7 (20) : 29835 - 29863
  • [25] Preclinical diagnosis of parkinson’s disease: Are we there yet?
    Andrew Siderowf
    Matthew B. Stern
    Current Neurology and Neuroscience Reports, 2006, 6 : 295 - 301
  • [26] Development of a new preclinical model of Parkinson’s disease
    Alexandra Le Bras
    Lab Animal, 2020, 49 : 219 - 219
  • [27] Development of a new preclinical model of Parkinson's disease
    Le Bras, Alexandra
    LAB ANIMAL, 2020, 49 (08) : 219 - 219
  • [28] Preclinical development of gene therapy for Parkinson's disease
    Porras, Gregory
    Bezard, Erwan
    EXPERIMENTAL NEUROLOGY, 2008, 209 (01) : 72 - 81
  • [29] Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics?
    Tropea, Thomas F.
    Chen-Plotkin, Alice
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (09):
  • [30] Do you need Lewy bodies to diagnose Parkinson's disease? NO
    Mizuno, Y
    MOVEMENT DISORDERS, 2004, 19 : S16 - S17
12345